Buscar
Mostrando ítems 21-30 de 37
Artículo
Metabolic-associated fatty liver disease: From simple steatosis toward liver cirrhosis and potential complications. Proceedings of the Third Translational Hepatology Meeting, organized by the Spanish Association for the Study of the Liver (AEEH)
(Elsevier Doyma, 2022)
This is a meeting report of the 3rd Translational Hepatology Meeting held in Alicante, Spain, in October 2021. The meeting, which was organized by the Spanish Association for the Study of the Liver (AEEH), provided an ...
Artículo
An experimental DUAL model of advanced liver damage
(John Wiley & Sons, 2021)
Individuals exhibiting an intermediate alcohol drinking pattern in conjunction with signs of metabolic risk present clini cal features of both alcohol-associated and metabolic-associated fatty liver diseases. However, such ...
Artículo
Glutaminolysis-ammonia-urea Cycle Axis, Non-alcoholic Fatty Liver Disease Progression and Development of Novel Therapies
(XHP Publishing, 2022)
The prevalence of non-alcoholic fatty liver disease (NAFLD) is increasing worldwide, reflecting the current epidemics of obesity, insulin resistance, type 2 diabetes mellitus, and metabolic syndrome. NAFLD is ...
Artículo
Nonalcoholic fatty liver disease and the risk of metabolic comorbidities: how to manage in clinical practice
(Medycyna Praktyczna, 2020)
Nonalcoholic fatty liver disease (NAFLD) is a clinical condition that encompasses various forms of liver damage not caused by chronic alcohol consumption. In the absence of other etiologies, it ranges from steatosis to ...
Artículo
Contribution of Liver and Pancreatic Islet Crosstalk to β-Cell Function/Dysfunction in the Presence of Fatty Liver
(Frontiers Media S.A., 2022)
Tissue-to-tissue crosstalk regulates organ function, according to growing data. This phenomenon is relevant for pancreatic b-cells and the liver, as both tissues are involved in glucose homeostasis and lipid metabolism. ...
Tesis Doctoral
Predictores de reingreso precoz en población con cirrosis hepática
(2023-06-26)
La cirrosis hepática es una enfermedad crónica que se asocia a una gran morbi-mortalidad, a menudo con requerimiento de ingreso hospitalario si aparece una complicación, y a un gran coste socio-económico. En este sentido, ...
Artículo
General overview about the current management of nonalcoholic fatty liver disease
(ADIS INTERNATIONAL LTD, 2022)
Nonalcoholic fatty liver disease includes a wide spectrum of manifestations from simple steatosis to nonalcoholic steatohepa titis, fbrosis, and eventually cirrhosis or even hepatocellular carcinoma. This disorder is also ...
Artículo
Liver injury in non-alcoholic fatty liver disease is associated with urea cycle enzyme dysregulation
(Nature Publishing Group, 2022)
The main aim was to evaluate changes in urea cycle enzymes in NAFLD patients and in two preclinical animal models mimicking this entity. Seventeen liver specimens from NAFLD patients were included for immunohistochemistry ...
Artículo
Inhibition of ATG3 ameliorates liver steatosis by increasing mitochondrial function
(Elsevier, 2022)
Background & Aims: Autophagy-related gene 3 (ATG3) is an enzyme mainly known for its actions in the LC3 lipidation pro cess, which is essential for autophagy. Whether ATG3 plays a role in lipid metabolism or contributes ...
Artículo
Liver stiffness accuracy by magnetic resonance elastography in histologically proven non-alcoholic fatty liver disease patients: a Spanish cohort
(Editorial Garsi, 2023)
Objectives: to evaluate the performance of magnetic resonance elastography (MRE) to stage liver fibrosis in patients with histologically confirmed nonalcoholic fatty liver disease (NAFLD) and to assess the impact of potential ...